Rafferty Asset Management, LLC

Position in OCGN — Ocugen, Inc.

CIK 1389426 New York, NY

Position in OCGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$512,052

-$278,900 QoQ

Shares Held

282,902

-64.5% QoQ

Ownership

0.084%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Rafferty Asset Management, LLC holds $380,107,116 across 136 Biotechnology names. OCGN ranks #116 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	54,572	$24,368,580
2	REGN	Regeneron Pharmaceuticals, Inc.	29,589	$22,861,644
3	INSM	INSMED Inc	116,069	$18,979,602
4	ALNY	Alnylam Pharmaceuticals, Inc.	50,553	$16,726,471
5	MRNA	Moderna, Inc.	114,194	$5,801,055
6	INCY	Incyte Corp	60,565	$5,700,377
7	MDGL	Madrigal Pharmaceuticals, Inc.	10,452	$5,471,308
8	TGTX	Tg Therapeutics, Inc.	160,802	$5,341,842

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$512,052	282,902	-64.5%	Shares	Sole	2026-05-15
2024-09-30	$790,952	797,331	-26.0%	Shares	Sole	2024-11-13
2024-06-30	$1,669,415	1,077,042	-56.4%	Shares	Sole	2024-08-13
2022-12-31	$3,212,521	2,471,170	+27.8%	Shares	Sole	2023-02-13
2022-09-30	$3,442,354	1,933,907	+39.6%	Shares	Sole	2022-11-14
2022-06-30	$3,145,616	1,385,734	-36.5%	Shares	Sole	2022-08-12
2022-03-31	$7,202,250	2,182,500	+121.4%	Shares	Sole	2022-05-13
2021-12-31	$4,484,684	985,645	+126.2%	Shares	Sole	2022-02-10
2021-09-30	$3,129,072	435,804	+5.9%	Shares	Sole	2021-11-10
2021-06-30	$3,303,806	411,433	+23.5%	Shares	Sole	2021-08-10
2021-03-31	$2,262,298	333,181	—	Shares	Sole	2021-05-10
No filing history on record for this holder in this stock.